Ładuje się......
Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation
OBJECTIVES: Since the introduction of the German health care reform in January 2011, an early benefit assessment (EBA) is required for all new medicines. Pharmaceutical manufacturers have to submit a benefit dossier for evaluation by the Institute for Quality and Efficiency in Health Care (IQWiG). A...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Springer Berlin Heidelberg
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4059963/ https://ncbi.nlm.nih.gov/pubmed/23771769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10198-013-0495-y |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|